Abstract
1,4-Dioxane is an important groundwater contaminant. Pseudonocardia sp. strain ENV478 degrades 1,4-dioxane via cometabolism after the growth on tetrahydrofuran (THF) and other carbon sources. Here, we have identified a THF monooxygenase (thm) in ENV478. The thm genes are transcribed constitutively and are induced to higher levels by THF. Decreased translation of the thmB gene encoding one of the monooxygenase subunits by antisense RNA resulted in the loss of its ability to degrade THF and 1,4-dioxane. This is the first study to link thm genes to THF degradation, as well as the cometabolic oxidation of 1,4-dioxane.
Journal Section:
Short Communication
References
1.
Bernhardt D, Diekmann H: Degradation of dioxane, tetrahydrofuran and other cyclic ethers by an environmental Rhodococcus strain. Appl Microbiol Biotechnol 1991;36:120–123.
2.
Chiba K, Hoshino Y, Ishino K, Kogure T, Mikami Y, Uehara Y, Ishikawa J: Construction of a pair of practical Nocardia-Escherichia coli shuttle vectors. Jpn J Infect Dis 2007;60:45–47.
3.
Daye KJ, Groff JC, Kirpekar AC, Mazumder R: High efficiency degradation of tetrahydrofuran (THF) using a membrane bioreactor: identification of THF-degrading cultures of Pseudonocardia sp. strain M1 and Rhodococcusruber isolate M2. J Ind Microbiol Biotechnol 2003;30:705–714.
4.
DeRosa CT, Wilbur S, Holler J, Richter P, Stevens YW: Health evaluation of 1,4-dioxane. Toxicol Ind Health 1996;12:1–43.
5.
Kim YH, Engesser KH, Kim SJ: Physiological, numerical and molecular characterization of alkyl ether-utilizing rhodococci. Environ Microbiol 2007;9:1497–1510.
6.
Kim YM, Jeon JR, Murugesan K, Kim EJ, Chang YS: Biodegradation of 1,4-dioxane and transformation of related cyclic compounds by a newly isolated Mycobacterium sp. PH-06. Biodegradation 2009;20:511–519.
7.
Kotani T, Yamamoto T, Yurimoto H, Sakai Y, Kato N: Propane monooxygenase and NAD+-dependent secondary alcohol dehydrogenase in propane metabolism by Gordonia sp. strain TY-5. J Bacteriol 2003;185:7120–7128.
8.
Kämpfer P, Kohlweyer U, Thiemer B, Andreesen JR: Pseudonocardiatetrahydrofuranoxydans sp. nov. Int J Syst Evol Microbiol 2006;56:1535–1538.
9.
Liu W, Saint DA: A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 2002;302:52–59.
[PubMed]
10.
Mahendra S, Alvarez-Cohen L: Kinetics of 1,4-dioxane biodegradation by monooxygenase-expressing bacteria. Environ Sci Technol 2006;40:5435–5442.
11.
Parales RE, Adamus JE, White N, May HD: Degradation of 1,4-dioxane by an actinomycete in pure culture. Appl Environ Microbiol 1994;60:4527–4530.
12.
Sales CM, Mahendra S, Grostern A, Parales RE, Goodwin LA, Woyke T, Nolan M, Lapidus A, Chertkov O, Ovchinnikova G, Sczyrba A, Alvarez-Cohen L: Genome sequence of the 1,4-dioxane-degrading Pseudonocardiadioxanivorans strain CB1190. J Bacteriol 2011;193:4549–4550.
13.
Thiemer B, Andreesen JR, Schräder T: The NADH-dependent reductase of a putative multicomponent tetrahydrofuran mono-oxygenase contains a covalently bound FAD. Eur J Biochem 2001;268:3774–3782.
14.
Thiemer B, Andreesen JR, Schräder T: Cloning and characterization of a gene cluster involved in tetrahydrofuran degradation in Pseudonocardia sp. strain K1. Arch Microbiol 2003;179:266–277.
15.
Vainberg S, McClay K, Masuda H, Root D, Condee C, Zylstra GJ, Steffan RJ: Biodegradation of ether pollutants by Pseudonocardia sp. strain ENV478. Appl Environ Microbiol 2006;72:5218–5224.
16.
Wilson T, de Lisle GW, Marcinkeviciene JA, Blanchard JS, Collins DM: Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacteriumbovis has virulence properties. Microbiology 1998;144:2687–2695.
[PubMed]
17.
Zenker MJ, Borden RC, Barlaz MA: Mineralization of 1,4-dioxane in the presence of a structural analog. Biodegradation 2000;11:239–246.
© 2012 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2012
You do not currently have access to this content.
